Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC G5-7 25mg | 939681-36-4 | 25 MG
SDP

Catalog No. 5000308005
Encompass_Preferred

G5-7 is an orally active, allosteric JAK2 inhibitor used for research applications. It selectively inhibits JAK2-mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3, and has been reported to induce cell cycle arrest, promote apoptosis, and exhibit antiangiogenic effects.

  • Allosteric JAK2 inhibitor with oral activity.
  • Selective inhibition of JAK2-mediated EGFR and STAT3 phosphorylation.
  • Reported to induce cell cycle arrest and apoptosis.
  • Exhibits antiangiogenic activity and glioma research relevance.
  • Provided as a solid; 25 mg pack available.
  • High purity (approximately 99.6%).

Catalog No. 50-003-08005 Supplier Medchemexpress LLC Supplier No. HY11545225MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

G5-7 is an orally active, allosteric JAK2 inhibitor used for research applications. It selectively inhibits JAK2-mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3, and has been reported to induce cell cycle arrest, promote apoptosis, and exhibit antiangiogenic effects.

  • Allosteric JAK2 inhibitor with oral activity.
  • Selective inhibition of JAK2-mediated EGFR and STAT3 phosphorylation.
  • Reported to induce cell cycle arrest and apoptosis.
  • Exhibits antiangiogenic activity and glioma research relevance.
  • Provided as a solid; 25 mg pack available.
  • High purity (approximately 99.6%).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.